Syncope, a transient loss of consciousness due to global cerebral hypoperfusion, is a common clinical presentation with a multifaceted etiology. Its management can be challenging, requiring a systematic approach to ensure accurate diagnosis and effective treatment.
Syncope is classified into three main categories: reflex, orthostatic hypotension, and cardiac. Reflex syncope, the most common type, includes vasovagal, situational, and carotid sinus hypersensitivity. Orthostatic hypotension is often drug-induced or due to autonomic failure. Cardiac syncope can be arrhythmic or structural, posing the highest risk of mortality.
A thorough history and physical examination are crucial. Key elements include the circumstances preceding the event, presence of prodromal symptoms, and recovery period. A detailed cardiovascular examination and orthostatic blood pressure measurements are essential. The ECG can provide valuable diagnostic clues.
The initial evaluation should aim to identify high-risk patients who require immediate intervention. If the cause remains unclear, further testing may include echocardiography, stress testing, or tilt-table testing. In some cases, prolonged cardiac monitoring or neurologic evaluation may be necessary.
Treatment depends on the underlying cause. For reflex syncope, patient education, avoidance of triggers, and physical counterpressure maneuvers can be effective. Orthostatic hypotension can be managed with lifestyle modifications and pharmacotherapy. Cardiac syncope may require medication, device therapy, or even surgery.
Mastering the approach to syncope involves understanding its diverse etiologies, conducting a thorough clinical assessment, and tailoring management to the underlying cause. By adopting a systematic approach, healthcare professionals can enhance patient care, improve outcomes, and reduce healthcare costs associated with this common yet complex condition.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation